Multichannel intraluminal impedance and pH monitoring in gastroesophageal reflux disease

Marcelo F. Vela

Research output: Contribution to journalReview article

7 Citations (Scopus)

Abstract

The role of acid is very well established in the pathogenesis of gastroesophagea/reflux disease and acid suppression constitutes the main approach to its medical treatment. With the current frequent use of proton pump inhibitors, we are seeing increasing numbers of patients in whom symptoms persist despite pharmacological acid suppression. Reflux monitoring has been traditionally performed through esophageal pH measurement to detect acid reflux (i.e., drops in esophageal pH to below 4.0). Multichannel intraluminal impedance and pH measurement constitutes an important development in reflux monitoring because, in addition to detecting acid reflux, it enables measurement of nonacid reflux (i.e., with a pH > 4.0, also known as 'weakly acidic' for pH > 4 but < 7, or 'weakly alkaline' if pH > 7), which may be responsible for symptoms in some patients who are being treated with proton pump inhibitors. This review describes the approach to measuring nonacid reflux, the possible mechanisms responsible for symptoms due to this type of reflux, the clinical importance of this phenomenon and available treatment options; and the role of multichannel intraluminal impedance and pH monitoring in the evaluation of refractory gastroesophageal reflux disease.

Original languageEnglish (US)
Pages (from-to)665-672
Number of pages8
JournalExpert Review of Gastroenterology and Hepatology
Volume2
Issue number5
DOIs
StatePublished - Oct 2008
Externally publishedYes

Fingerprint

Gastroesophageal Reflux
Electric Impedance
Acids
Proton Pump Inhibitors
Pharmacology
Therapeutics

Keywords

  • Gastroesophageal reflux disease
  • Impedance
  • Nonacid reflux

ASJC Scopus subject areas

  • Gastroenterology
  • Hepatology

Cite this

Multichannel intraluminal impedance and pH monitoring in gastroesophageal reflux disease. / Vela, Marcelo F.

In: Expert Review of Gastroenterology and Hepatology, Vol. 2, No. 5, 10.2008, p. 665-672.

Research output: Contribution to journalReview article

@article{095b8629dd5d4d0fab3b022e652f8b7f,
title = "Multichannel intraluminal impedance and pH monitoring in gastroesophageal reflux disease",
abstract = "The role of acid is very well established in the pathogenesis of gastroesophagea/reflux disease and acid suppression constitutes the main approach to its medical treatment. With the current frequent use of proton pump inhibitors, we are seeing increasing numbers of patients in whom symptoms persist despite pharmacological acid suppression. Reflux monitoring has been traditionally performed through esophageal pH measurement to detect acid reflux (i.e., drops in esophageal pH to below 4.0). Multichannel intraluminal impedance and pH measurement constitutes an important development in reflux monitoring because, in addition to detecting acid reflux, it enables measurement of nonacid reflux (i.e., with a pH > 4.0, also known as 'weakly acidic' for pH > 4 but < 7, or 'weakly alkaline' if pH > 7), which may be responsible for symptoms in some patients who are being treated with proton pump inhibitors. This review describes the approach to measuring nonacid reflux, the possible mechanisms responsible for symptoms due to this type of reflux, the clinical importance of this phenomenon and available treatment options; and the role of multichannel intraluminal impedance and pH monitoring in the evaluation of refractory gastroesophageal reflux disease.",
keywords = "Gastroesophageal reflux disease, Impedance, Nonacid reflux",
author = "Vela, {Marcelo F.}",
year = "2008",
month = "10",
doi = "10.1586/17474124.2.5.665",
language = "English (US)",
volume = "2",
pages = "665--672",
journal = "Expert Review of Gastroenterology and Hepatology",
issn = "1747-4124",
publisher = "Expert Reviews Ltd.",
number = "5",

}

TY - JOUR

T1 - Multichannel intraluminal impedance and pH monitoring in gastroesophageal reflux disease

AU - Vela, Marcelo F.

PY - 2008/10

Y1 - 2008/10

N2 - The role of acid is very well established in the pathogenesis of gastroesophagea/reflux disease and acid suppression constitutes the main approach to its medical treatment. With the current frequent use of proton pump inhibitors, we are seeing increasing numbers of patients in whom symptoms persist despite pharmacological acid suppression. Reflux monitoring has been traditionally performed through esophageal pH measurement to detect acid reflux (i.e., drops in esophageal pH to below 4.0). Multichannel intraluminal impedance and pH measurement constitutes an important development in reflux monitoring because, in addition to detecting acid reflux, it enables measurement of nonacid reflux (i.e., with a pH > 4.0, also known as 'weakly acidic' for pH > 4 but < 7, or 'weakly alkaline' if pH > 7), which may be responsible for symptoms in some patients who are being treated with proton pump inhibitors. This review describes the approach to measuring nonacid reflux, the possible mechanisms responsible for symptoms due to this type of reflux, the clinical importance of this phenomenon and available treatment options; and the role of multichannel intraluminal impedance and pH monitoring in the evaluation of refractory gastroesophageal reflux disease.

AB - The role of acid is very well established in the pathogenesis of gastroesophagea/reflux disease and acid suppression constitutes the main approach to its medical treatment. With the current frequent use of proton pump inhibitors, we are seeing increasing numbers of patients in whom symptoms persist despite pharmacological acid suppression. Reflux monitoring has been traditionally performed through esophageal pH measurement to detect acid reflux (i.e., drops in esophageal pH to below 4.0). Multichannel intraluminal impedance and pH measurement constitutes an important development in reflux monitoring because, in addition to detecting acid reflux, it enables measurement of nonacid reflux (i.e., with a pH > 4.0, also known as 'weakly acidic' for pH > 4 but < 7, or 'weakly alkaline' if pH > 7), which may be responsible for symptoms in some patients who are being treated with proton pump inhibitors. This review describes the approach to measuring nonacid reflux, the possible mechanisms responsible for symptoms due to this type of reflux, the clinical importance of this phenomenon and available treatment options; and the role of multichannel intraluminal impedance and pH monitoring in the evaluation of refractory gastroesophageal reflux disease.

KW - Gastroesophageal reflux disease

KW - Impedance

KW - Nonacid reflux

UR - http://www.scopus.com/inward/record.url?scp=55349129212&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=55349129212&partnerID=8YFLogxK

U2 - 10.1586/17474124.2.5.665

DO - 10.1586/17474124.2.5.665

M3 - Review article

C2 - 19072344

AN - SCOPUS:55349129212

VL - 2

SP - 665

EP - 672

JO - Expert Review of Gastroenterology and Hepatology

JF - Expert Review of Gastroenterology and Hepatology

SN - 1747-4124

IS - 5

ER -